bearish
MabPharm (迈博医药) IPO: Thoughts on Valuation (Part 2)
861 Views15 Apr 2019 11:34
MabPharm is expected to launch its IPOsoon. In our previous insights (links provided below), we provided a detailed analysis of the company's core...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (25 May 2019) - ESR Cayman, Hansoh Pharma, Tai Hing, China East Edu, Haitong UniTrust25 May 2019
- ECM Weekly (18 May 2019) - MabPharm, Frontage, Mulsanne, Xinyi Energy, Helenbergh18 May 2019
- MabPharm (迈博医药) IPO: Fairly Valued and Lacks Biotech Investors17 May 2019
- MabPharma (迈博医药) IPO: Assembled for a Trade?21 Feb 2019
- Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio30 Jan 2019
x